CRWV tumbled 12% on August 18 to $93.17, reversing much of the post-earnings euphoria, yet the short-selling community that drove the stock's summer storyline has notably declined to reload.
The most striking tension in today's data is the gap between a sharp single-day sell-off and a short base that keeps shrinking. Short interest now sits at 14.7% of the free float — still elevated in absolute terms, but down nearly 10% on the week and almost 38% from where it was a month ago. At the July peak, short interest exceeded 100 million shares; the current reading is under 57 million. Bears who spent the summer building into the August 11 earnings print have not come back after covering post-earnings. That divergence — price falls hard, shorts don't bite — is the defining feature of the week.
The lending market reinforces that picture. Availability has loosened considerably, with 234% availability relative to shares already borrowed — more than double the minimum of 97% recorded during the tightest stretch of the past year. Borrow costs are running around 0.5%, essentially unchanged on the week and barely above what any liquid large-cap would charge. There is no friction in the lending pool signalling a new wave of short demand. Options traders are also not sounding an alarm: the put/call ratio edged up to 0.75 on the sell-off day, slightly above its 20-day average of 0.72, but less than one standard deviation above that mean. That is a mild uptick in hedging, not a defensive panic.
The Street response to last week's earnings is the clearest bullish data point. Citigroup raised its target to $159 on August 14. Truist lifted to $155. Wells Fargo held at $160 Overweight. Piper Sandler is at $153. The pushback comes from Barclays, which raised its Equal-Weight target to $105 — still below the current price — and Bernstein, which maintains Underperform with a $74 target even after nudging it up from $67. JP Morgan's Neutral at $120 sits in the middle, accepting the growth story without endorsing the valuation. The mean target near $140 implies roughly 50% upside from Tuesday's close, though the $250 Rosenblatt outlier inflates that figure. The bull case rests on AI infrastructure demand, pricing power, and margin expansion; the bear case names supplier concentration risk and the sustainability of long-term contract pricing.
Magnetar Capital — the stock's second-largest holder with roughly 9.4% of shares — sold just over $8 million worth across several transactions on August 14, the day after earnings enthusiasm peaked. The trades are small relative to Magnetar's total position and carry low significance scores, but the direction is worth noting. Insiders and affiliated holders have been net sellers in aggregate over the past 90 days despite a positive net share count, and co-founder Michael Intrator trimmed 5.7 million shares in the most recent reporting period. These moves don't constitute a red flag on their own, but they sit awkwardly alongside a Street that is near-unanimously bullish on the growth trajectory.
The earnings history adds useful context. After the August 11 print, CRWV jumped 22% the following day, then gave back most of that over the subsequent five sessions — a pattern that mirrors the earlier February event, where a smaller initial pop gave way to an 18% five-day drift. Tuesday's 12% decline follows that template closely. The next earnings event is flagged for November 12, giving the market roughly three months to decide whether the post-print giveback is a buying opportunity or a signal that the valuation has run ahead of fundamentals — and whether bears, who have been conspicuously absent this week, eventually return to re-establish pressure.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
